CoChat

Oestrogens prevent the increase of human serum soluble interleukin‐6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro

Girasole, Giuseppe, Giuliani, Nicola, Modena, Alberto Bacchi, Passeri, Giovanni, Pedrazzoni, Mario · 1999 · Clinical Endocrinology
Cited by 46

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Interleukin‐6 (IL‐6) seems to be a key mediator of the increased bone loss that follows loss of ovarian function. Based on this and on evidence that oestrogen deficiency may also increase cell sensitivity to IL‐6, we studied the effects of ovariectomy and of oestrogen replacement therapy on the serum levels of IL‐6 and of soluble IL‐6 receptor (sIL‐6R) in vivo. DESIGN AND PATIENTS: Thirty‐seven fertile women undergoing surgery for benign uterine diseases were divided into 3 groups and monitored for 12 months: hysterectomized women (n = 9), ovariectomized untreated women (n = 12) and ovariectomized women starting treatment with transdermal estradiol (E 2, 50 μg/d) 1 month after surgery (n = 16). RESULTS: Hysterectomy alone caused no significant changes of sIL6R whereas serum levels of sIL‐6R rose progressively after ovariectomy (mean ± SEM: 31 ± 9% and 38 ± 7% over baseline, at 6 and 12 months, respectively; P < 0.01). Oestrogen replacement therapy prevented the increase of sIL6R over a 1‐year period. A similar pattern was also found for serum IL‐6 but the changes did not reach statistical significance. In ovariectomized (OVX) women there were significant correlations between serum sIL‐6R levels and FSH (r = 0.59; P < 0.01), oestradiol (r = − 0.43; P < 0.01), testosterone (r = − 0.41; P < 0.05), osteocalcin (r = 0.42; P < 0.05) and bone alkaline phosphatase (r = 0.44; P < 0.05). To examine whether oestrogen directly regulates sIL‐6R secretion by bone cells, we studied in vitro the basal and phorbol ester (PMA) stimulated release of sIL‐6R in a human osteoblastic cell‐line (MG‐63) and in a tumour‐derived osteoclastic cell line (GCT‐51). Osteoblastic (but not osteoclastic) cells spontaneously produced considerable amounts of sIL‐6R and the protein kinase‐C activator PMA (10−8 M) increased the release of sIL‐6R by osteoblasts more than 3‐fold. More strikingly, 17β E 2 (but not 17α) significantly inhibited both the spontaneous‐ and PMA‐induced release of sIL‐6R by osteoblastic cells (P < 0.05). CONCLUSIONS: These results indicate that oestrogen loss causes alterations of the IL‐6 system, and that sIL‐6R is under the direct inhibitory control of oestrogens both in vivo and in vitro.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2265.1999.00896.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 46

Metadata

Authors
Girasole, G., Giuliani, N., Modena, A. B., Passeri, G., & Pedrazzoni, M.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1999-12
Volume
51
Issue
6
Pages
801-807
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2060149005
Cited by
46
References
3
FWCI
0.68
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oestrogens prevent the increase of human serum soluble interleukin‐6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro. https://app.cochat.ai/papers/10.1046/j.1365-2265.1999.00896.x
The paper
Girasole, G., Giuliani, N., Modena, A. B., Passeri, G., & Pedrazzoni, M. (1999). Oestrogens prevent the increase of human serum soluble interleukin‐6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.1999.00896.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.